» Articles » PMID: 19944185

TP53 Mutation Profile of Esophageal Squamous Cell Carcinomas of Patients from Southeastern Brazil

Abstract

Esophageal cancer (EC) is among the 10 most common and fatal malignacies in the world, presenting a marked geographic variation in incidence rates between and within different countries. The TP53 tumor suppressor gene is highly mutated in esophageal tumors and its mutation pattern can offer clues to the etiopathology of the tumor. As Brazil presents one of the highest incidence areas in the West, a deeper knowledge of the molecular mechanisms related to EC development in the Brazilian population is needed. We analyzed the mutation profile of 110 esophageal squamous cell carcinomas (ESCC) of patients from Southeastern Brazil (Rio de Janeiro and São Paulo) and collected data regarding alcohol intake and tobacco smoking. We detected 41 mutations in tumor samples from 38 patients. There was no association between mutation frequency and tobacco smoking or alcohol drinking. The most frequently mutated codons were 179, 214, 220 and 248. Codons 179, 220 and 248 are hot-spots for ESCC, but codon 214 presents only 0.7% of the mutations registered in the IARC database. The mutation profile revealed a high percentage of mutations at A:T base pairs (34.1%) followed by deletions (17.1%). We concluded that the mutation profile detected in this study is different from that of patients from Southern Brazil but very similar to that previously seen in French patients, being characterized by a high frequency of mutations at A:T base pairs, which may be associated with acetaldehyde, the metabolic product of ethanol.

Citing Articles

Profile of esophageal squamous cell carcinoma mutations in Brazilian patients.

Munari F, Dos Santos W, Evangelista A, Carvalho A, Pastrez P, Bugatti D Sci Rep. 2021; 11(1):20596.

PMID: 34663841 PMC: 8523676. DOI: 10.1038/s41598-021-00208-7.


Mutations, Differential Gene Expression, and Chimeric Transcripts in Esophageal Squamous Cell Carcinoma Show High Heterogeneity.

de Souza-Santos P, Lima S, Nicolau-Neto P, Boroni M, Meireles Da Costa N, Brewer L Transl Oncol. 2018; 11(6):1283-1291.

PMID: 30172240 PMC: 6121831. DOI: 10.1016/j.tranon.2018.08.002.


Atorvastatin Downregulates Methyl Methanesulfonate and Cyclophosphamide Alkylation-Mediated Cellular and DNA Injuries.

Araujo-Lima C, Christoni L, Justo G, Soeiro M, Aiub C, Felzenszwalb I Oxid Med Cell Longev. 2018; 2018:7820890.

PMID: 29849914 PMC: 5903342. DOI: 10.1155/2018/7820890.


International cancer seminars: a focus on esophageal squamous cell carcinoma.

Murphy G, McCormack V, Abedi-Ardekani B, Arnold M, Camargo M, Dar N Ann Oncol. 2017; 28(9):2086-2093.

PMID: 28911061 PMC: 5834011. DOI: 10.1093/annonc/mdx279.


The potential of molecular markers to improve interventions through the natural history of oesophageal squamous cell carcinoma.

Meireles Da Costa N, Lima S, de Almeida Simao T, Pinto L Biosci Rep. 2013; 33(4).

PMID: 23837802 PMC: 3747595. DOI: 10.1042/BSR20130063.